| Name | Title | Contact Details |
|---|
Aurelia Osborn Fox Memorial Hospital is a Oneonta, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
Central States Health & Life Co. of Omaha is a Omaha, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
PLUS Diagnostics is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Union, NJ. To find more information about PLUS Diagnostics, please visit www.plusdx.com
AlwaysCare Benefits is a Baton Rouge, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.